GLP-1s Like Ozempic, Mounjaro May Lower Fracture Risk in Type 2 Diabetes

GLP-1 medications may help lower fragility-related fracture risk in people with type 2 diabetes. OLEKSANDRA TROIAN · Moment/Getty A new study found that GLP-1 medications may help reduce the risk of fragility fractures in people with type 2 diabetes. The largest fracture reductions were seen in hip, femur, and spine fractures. Because this is an observational study, it doesn’t prove that GLP-1 medications reduce fracture risk. A new study reports that people with type 2 diabetes who take GLP-1 medications may lower their risk for fragility-related fractures. Fragility fractures occur when bones are fragile enough to break from a fall that wouldn’t normally break a healthy bone. While the findings are encouraging, the study is observational and therefore cannot prove that GLP-1 drugs, such as Ozempic or Mounjaro, reduce the risk of fractures. The researchers acknowledged this limitation and agree that further studies are needed. The findings were published on July 24 in JAMA Network Open. “GLP-1 RAs are being used by a rapidly growing number of patients,” said the study’s primary author, Christopher D. Hamad, MD, research fellow in the Department of Orthopedic Sur…